Conexeu Sciences Inc. (CNXU) Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Industry: Biotechnology
Conexeu Sciences Inc. NASDAQ:CNXU Healthcare · Biotechnology
AH Close $3.31 vs close AH Close $3.31 +6.77% vs close
8-K 10-Q S-1 S-1/A 3 4 4/A 13D 13D/A 13G 13G/A 424B3 424B4 D D/A C C/A C-AR
Form Description Filed Links D 10/21/26 Oct 21, 2026 424B3 10/21/26 Oct 21, 2026 8-K 10/20/26 Oct 20, 2026 4 10/19/26 Oct 19, 2026 D 9/29/26 Sep 29, 2026 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
9/28/26 Sep 28, 2026 13D/A Beneficial Ownership Report (Active, Amended)
9/15/26 Sep 15, 2026 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
9/15/26 Sep 15, 2026 D 9/15/26 Sep 15, 2026 424B3 9/15/26 Sep 15, 2026 10-Q 9/14/26 Sep 14, 2026 424B3 9/10/26 Sep 10, 2026 8-K 9/10/26 Sep 10, 2026 4/A 9/9/26 Sep 9, 2026 4 9/9/26 Sep 9, 2026 13G/A Beneficial Ownership Report (Amended)
9/4/26 Sep 4, 2026 13G Beneficial Ownership Report
9/4/26 Sep 4, 2026 D 8/31/26 Aug 31, 2026 13D Beneficial Ownership Report (Active)
8/18/26 Aug 18, 2026 13G Beneficial Ownership Report
8/18/26 Aug 18, 2026 13G Beneficial Ownership Report
8/14/26 Aug 14, 2026 13G Beneficial Ownership Report
8/14/26 Aug 14, 2026 13G Beneficial Ownership Report
8/14/26 Aug 14, 2026 D 7/31/26 Jul 31, 2026 13G Beneficial Ownership Report
7/28/26 Jul 28, 2026
